Le Lézard

Communiqués de presse par sujet : Essais cliniques / Découvertes médicales

2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

24 juillet 2018

07:00
GenomeDx Biosciences, a leader in the field of urologic cancer genomics, today announced that Palmetto GBA, a Medicare Administrative Contractor (MAC), has issued a Draft local coverage determination (LCD) and completed the public comment period for...

06:04
The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new data reinforcing the safety and efficacy of switching to SYMTUZAtm (D/C/F/TAF) for the treatment of HIV-1 regardless of prior treatment regimen among treatment-experienced...

06:00
Nucleix Ltd., a leading cancer detection and screening company, announced today that the multi-center European study results with its Bladder EpiChecktm  urine test for the detection of bladder cancer recurrence, were published in the European...

03:00
Biohaven Pharmaceutical Holding Company Ltd. ("Biohaven" or the "Company") announced today that it initiated a Phase 2/3 clinical trial of trigriluzole (BHV-4157), a novel glutamate modulator, in patients with mild-to-moderate Alzheimer's disease...


23 juillet 2018

16:29
Windtree Therapeutics, Inc. , a biotechnology company focused on developing aerosolized KL4 surfactant therapies for respiratory diseases, today announced that it has successfully completed design verification of its new proprietary aerosol delivery...

14:30
Increased public and private investments in Alzheimer's disease research have brought about a proliferation of potential therapeutic targets. Drugs and other interventions to hit those targets are moving into clinical trials. Other studies are...

12:28
The oral disease-modifying therapies (DMTs) dominate the first-line position among multiple sclerosis (MS) patients recently started on their first DMT, with one in five oral DMT starts driven primarily by the preference for an oral formulation,...

11:21
Perflow Medical, une société d'équipements médicaux située en Israël qui développe des outils innovants pour les interventions neurvasculaires, annonce les premiers cas cliniques du filet remodelant dynamique non occlusif Cascade plus tôt ce mois-ci...

11:12
Oxiplex® is an absorbable, synthetic viscoelastic gel that is applied following partial discectomy, with the intent to reduce postoperative leg pain, back pain and neurologic symptoms. "We are pleased that we now have...

11:00
For the first-time, researchers at IMBA - Institute of Molecular Biotechnology of the Austrian Academy of Sciences - develop organoids, that mimic the onset of brain cancer. This method not only sheds light on the complex biology of human brain...

10:35
A new study from the Stanford Cancer Institute finds that young women who are treated with chemotherapy for breast cancer but have residual tumor in either the breast or lymph nodes have higher chances of recurrence compared to those with no evidence...

09:00
Physicians Seal, LLC® (PS) today announced favorable results from its REMfresh® Safety Update at 12 Months (REMSU-12) for REMfresh® Ion-Powered Melatonintm, a real-world surveillance study reporting on the safety and tolerability profile of REMfresh®...

08:05
Biocept, Inc. , a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of patients diagnosed with cancer, announces that it will work with Moores Cancer...

08:01
Alkahest Inc. ("Alkahest"), a clinical-stage biotechnology company focused on developing innovative therapies to treat Alzheimer's Disease and other age-related diseases, today announced upcoming presentations at the Alzheimer's Association...

08:01
Dermtreat, a clinical-stage biopharmaceutical company focused on mucosal diseases, today announced treatment of the first patient in a Phase 2b clinical trial of Rivelin® Clobetasol patch (Rivelin®-CLO) for oral lichen planus (OLP). Rivelin-CLO is...

08:00
Allergan plc , a leading global pharmaceutical company, today announced the U.S. Food and Drug Administration has granted Fast Track  designation for AGN-241751, an investigational new treatment for Major Depressive Disorder (MDD).  AGN-241751 is a...

08:00
Tolero Pharmaceuticals, Inc., a clinical-stage company focused on developing novel therapeutics for hematological and oncological diseases, today announced that it has initiated the second stage of the Phase 2 Zella 201 study evaluating the efficacy...

07:00
Sangamo Therapeutics, Inc. today announced treatment of the first patient in the Phase 1/2 clinical trial evaluating SB-318, an investigational in vivo genome editing therapy for patients with mucopolysaccharidosis type I (MPS I, Hurler syndrome)...

03:00
Perflow Medical, an Israeli-based medical device company that develops innovative tools for neurovascular interventions, announces the first clinical cases of the Cascade Dynamic Non-Occlusive Remodeling Net earlier this month by Dr. Alejandro...

02:37
Regen BioPharma Inc.'s and lead candidate drug, RG-NAE005, was tested for its maximum tolerated dose in mice and showed no signs of toxicity. Regen has methodically optimized small molecules that bind to, and activate, the NR2F6 nuclear receptor....


22 juillet 2018

09:01
The first dementia prevalence data from a large population of lesbian, gay and bisexual older adults was reported today at the 2018 Alzheimer's Association International Conference in Chicago. Researchers from University of California, San Francisco...


20 juillet 2018

09:30
Eli Lilly and Company today announced that new results from a number of studies across the company's Alzheimer's disease pipeline will be presented at the Alzheimer's Association International Conference (AAIC) in Chicago, July 22-26, 2018. Nearly...

09:00
Global biotherapeutics leader CSL Behring today announced that it will support the presentation of 14 scientific posters at the 2018 annual meeting of the Peripheral Nerve Society (PNS).  Most notably, neuromuscular medical research from the PATH...

08:00
Feeding America, the nation's largest hunger-relief organization with 200 member food banks, concluded a two-year, randomized controlled research trial to help low-income Americans better manage and control type 2 diabetes. The study, which was...


19 juillet 2018

23:46
Norgine B.V. a annoncé aujourd'hui que les résultats de l'étude MORA de phase III portant sur PLENVU® ont été publiés dans ENDOSCOPY, une revue médicale mensuelle évaluée par des pairs au nom de la Société européenne d'endoscopie gastro-intestinale....

20:37
Shanghai Green Valley Pharmaceutical Co., Ltd. (Green Valley) a annoncé aujourd'hui que son étude de phase 3 des capsules d'oligomannurarate de sodium (GV-971) sur la maladie d'Alzheimer d'intensité légère à modérée a atteint son critère d'évaluation...

16:45
Jazz Pharmaceuticals plc announced today that data from the pivotal Phase 3 study of Vyxeos® (daunorubicin and cytarabine) liposome for injection compared to standard of care cytarabine and daunorubicin (7+3) were published online in the Journal of...

14:47
Shanghai Green Valley Pharmaceutical Co., Ltd. (Green Valley) a annoncé aujourd'hui que son étude de phase 3 d'administration de capsules d'oligomannurarate de sodium (GV-971) à des patients atteints légèrement à modérément de la maladie d'Alzheimer...

14:15
Alopexx Vaccine LLC today announced the publication of positive data for a veterinary vaccine demonstrating 91% protective efficacy in horse foals born to mares immunized in the last 3-6 weeks of pregnancy with its poly-N-acetyl glucosamine...

10:54
Alligator Bioscience , a biotechnology company developing antibody-based pharmaceuticals for tumor-directed immunotherapy, today announced that the company has submitted a clinical trial authorization (CTA) application to the relevant regulatory...

10:20
Scientists at the University of Birmingham, UK, are one step closer to developing an eye drop that could revolutionise treatment for age-related macular degeneration (AMD).        (Photo:...

09:08
Precision BioLogic today unveiled data from a study using a new kit for a Modified Nijmegen-Bethesda Assay (MNBA) at the International Society on Thrombosis and Haemostasis' Scientific and Standardization Committee (SSC) meeting in Dublin....

08:30
Aevi Genomic Medicine, Inc. (the Company) today announced that it received positive feedback from the United States Food and Drug Administration (FDA) on an improved version of the Company's lead development molecule, AEVI-001, identified as...

08:30
Norgine B.V. today announced that results from the PLENVU® Phase III MORA trial were published in ENDOSCOPY, a monthly peer-reviewed medical journal on behalf of the European Society of Gastrointestinal Endoscopy.      (Logo:...

08:00
GT Biopharma Inc. (GTBP) and (Euronext Paris: GTBP.PA) announced today a Material Transfer Agreement (MTA) between a Major Pharmaceutical Company and Dr. Daniel Vallera, Director, Section of Molecular Cancer Therapeutics at the Masonic Cancer Center,...

08:00
Enteris BioPharma, Inc., a biotechnology company developing innovative drug products built around its proprietary delivery technologies, congratulates Cara Therapeutics on the successful initiation of its Phase 2 clinical trial of Oral KORSUVAtm...

08:00
CARMELINA® (CArdiovascular safety and Renal Microvascular outcomE with LINAgliptin in patients with type 2 diabetes at high vascular risk) met its primary endpoint, defined as time to first occurrence of cardiovascular death, non-fatal myocardial...

08:00
Allergan plc, , a leading global pharmaceutical company and Molecular Partners (SIX: MOLN), a clinical-stage biopharmaceutical company developing a new class of drugs known as DARPin® therapies, today announced the release of two positive clinical...

06:15
In the news release, Innovative Alzheimer's Treatment from China Concludes Phase 3 Clinical Trials, issued 19-Jul-2018 by Shanghai Green Valley Pharmaceutical Co., Ltd over PR Newswire, we are advised by the company that the second sentence should...

06:00
Soligenix, Inc. (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, today issued an update letter from its President and...

02:33
Shanghai Green Valley Pharmaceutical Co., Ltd. (Green Valley) today announced that its Phase 3 Study of Sodium Oligomannurarate (GV-971) Capsules on mild-to-moderate Alzheimer's disease met its primary endpoint. This randomized, double-blinded and...


18 juillet 2018

17:05
BioArctic AB (publ) . As previously announced, the BAN2401 Phase 2b clinical study results will be presented in an oral session at the 2018 Alzheimer's Association International Conference (AAIC) on July 25, 2018 at 3:30 p.m. CDT in Chicago, IL, as...

14:27
Vapotherm, Inc. today announced the publication of a key prospective, multi-center randomized controlled trial.  The study demonstrates the non-inferiority of High Velocity Nasal Insufflation (HVNI) to traditional Non-invasive Positive Pressure...

13:03
Avella Specialty Pharmacy has just published new data showing that automated patient engagement, in combination with patient monitoring and trigger-based pharmacist interventions, have a significant impact on patient adherence and persistence....

09:00
Takara Bio USA, Inc., (TBUSA, formerly Clontech Laboratories, Inc.), a wholly owned subsidiary of Takara Bio Inc., is proud to announce that patent JP6336080B?covering the Smart-seq2 method, developed by Rickard Sandberg and exclusively licensed to...

08:45
CSSi, a global full-service patient recruitment company, today announced that its MyClinicalTrial ID (MCT ID) database has expanded to over one million patients. MCT ID was developed to improve the investigator site selection and patient recruitment...

08:00
Evolve BioSystems, Inc. (www.evolvebiosystems.com) announced publication of a study showing that two weeks of supplementation with Bifidobacterium longum subsp. infantis EVC001 (B. infantis EVC001, currently available to consumers as Evivo® baby...

08:00
PainReform Ltd, developer of a proprietary reformulation technology, has received FDA approval to conduct two pivotal Phase III clinical trials for post-operative pain relief in soft and hard tissue. "This green light from the FDA enables us to...

08:00
Eisai Inc., the U.S. pharmaceutical subsidiary of Eisai Co., Ltd., announces today that 13 posters and presentations from its robust Alzheimer's disease pipeline, including the Phase 2 clinical study (Study 201) of the anti-amyloid beta (A?)...

07:00
CTI BioPharma Corp. today announced that it recently conducted a Type B meeting with the U.S. Food and Drug Administration (FDA) for its lead product candidate pacritinib. The purpose of the meeting was to discuss the regulatory pathway for...

2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20